Eledon Pharmaceuticals
ELDN
ELDN
16 hedge funds and large institutions have $13.6M invested in Eledon Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.01% less ownership
Funds ownership: 2% → 1.99% (-0.01%)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$159K | |
| 2 | +$48.1K | |
| 3 | +$40K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$17.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.39K |
Top Sellers
| 1 | -$129K | |
| 2 | -$128K | |
| 3 | -$3.78K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$1.04K |